Statistically significant bacteria for Post-exertional malaise: Next-day soreness after everyday activities using biomesight lab pipeline and genus taxonomy

This page has been revised to make visually clear the shifts and significance to non-statisticians. Statisticians are welcomed to download the full data and process it themselves.

Shift - the direction that the top and bottom 16% is expected to change. Note that the mean, median and other standard statistical method may not alter significantly
If there was independence - then the number below 16%ile and above 84%ile should be almost the same. Percentile is a uniform distribution and not a gaussian distribution
Prevalence - How often this taxa is identified by this lab pipeline
Chi2 with one degree of freedom - we evaluate two chi2 and report the highest only

Using this information have found significantly accurate prediction of symptoms on new people using the same pipeline. The same FASTQ file processed thru ubiome, Ombre, Biomesight and sequentia biotech; resulted in different genus being reported with different amounts. Clearly, the associations is processing pipeline dependent.

This table is regenerated every month on the 2nd using the latest data
Bacteria	Shift	Prevalence	Number below 16%ile	Number above 84%ile	Chi2
Bacteroides	increases	100	9.0	33.0	12.69
Selenomonas	increases	94.39	15.0	28.0	10.04
Thiocapsa	increases	26.8	0.0	17.0	21.93
Nostoc	increases	39.23	0.0	13.0	13.03
Erysipelothrix	increases	84.84	7.0	28.0	14.24
Bifidobacterium	decrease	98.18	28.0	11.0	9.33
Salinicoccus	decrease	44.62	16.0	8.0	10.76
Dethiosulfovibrio	increases	57.92	5.0	17.0	6.81
Holdemania	increases	87.45	7.0	27.0	11.86
Slackia	decrease	87	21.0	13.0	7.09
Hymenobacter	increases	63.87	3.0	23.0	22
Thermicanus	decrease	84.69	27.0	14.0	10.63
Coprobacillus	increases	97.35	8.0	29.0	10.56
Faecalibacterium	decrease	99.93	33.0	18.0	12.69
Caldilinea	increases	32.74	6.0	11.0	7.36
Odoribacter	increases	89.62	14.0	28.0	7.76
Sharpea	increases	42.72	7.0	18.0	7.35
Phocaeicola	increases	99.93	10.0	30.0	8.14

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]